Scholtz & Company, LLC
- SEC CIK
- 0001606134
- Latest filing
- Aug 11, 2026
PFE holding history
Pfizer Inc in every 13F filed by Scholtz & Company, LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
PFE overviewAll 13F holders of PFEFull Q2 2026 holdings
- Shares (Q1 2026)
- 0
- Sold out in Q1 2026
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 9
- Since Q4 2023
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q1 2026 | 0 | $0 | 0.0% | −10,062−100.0% | Sold out | Holders |
| Q4 2025 | 10,062 | $250.5K | 0.1% | 00.0% | Unchanged | Holders |
| Q3 2025 | 10,062 | $256.4K | 0.1% | −4,000−28.4% | Reduced | Holders |
| Q2 2025 | 14,062 | $340.9K | 0.1% | 00.0% | Unchanged | Holders |
| Q1 2025 | 14,062 | $356.3K | 0.2% | −2,225−13.7% | Reduced | Holders |
| Q4 2024 | 16,287 | $432.1K | 0.2% | 00.0% | Unchanged | Holders |
| Q3 2024 | 16,287 | $471.3K | 0.2% | 00.0% | Unchanged | Holders |
| Q2 2024 | 16,287 | $455.7K | 0.2% | −1,575−8.8% | Reduced | Holders |
| Q1 2024 | 17,862 | $495.7K | 0.2% | −3,600−16.8% | Reduced | Holders |
| Q4 2023 | 21,462 | $618.0K | 0.3% | +21,462 | New | Holders |